Systemic spread of measles virus: Overcoming the epithelial and endothelial barriers

Thrombosis and Haemostasis

Volumn 102, Issue 6, 2009, Pages 1050-1056

  Ludlow, Martin ^a   Allen, Ingrid ^a   Schneider Schaulies, Jürgen ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cerebrovascular disease; Receptors; Viral infection

Indexed keywords

CD150 ANTIGEN; CELL RECEPTOR; MEASLES VACCINE; VIRUS ENVELOPE PROTEIN;

CLINICAL FEATURE; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEASLES; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EPITHELIUM; HOST-PATHOGEN INTERACTIONS; HUMANS; MEASLES; MEASLES VIRUS; MODELS, BIOLOGICAL; RECEPTORS, CELL SURFACE; VIRAL ENVELOPE PROTEINS;

EID: 72949106019     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-03-0202     Document Type: Review

References (81)

1. WHO. Progress in global measles control and mortality reduction, 2000-2007. Wkly Epidemiol Rec 2008; 83: 441-448.
2. Katz M. Clinical spectrum of measles. In: Billeter MA, ter Meulen v, editors. Measles Virus. Berlin, Heidelberg, New York: Springer-Verlag; 1995; p. 1-12.
3. von Pirquet C. Das Verhalten der kutanen Tuberkulin-Reaktion während der Masern. Dt Med Wochenschr 1908; 34: 1297-1300.
4. Borrow P, Oldstone MBA. Measles virus- mononuclear cell interactions. In: Billeter MA, ter Meulen V, editors. Measles Virus. Berlin, Heidelberg, New York: Springer-Verlag; 1995; p. 85-100.
5. Griffin DE. Immune responses during measles virus infection. In: Billeter MA, ter Meulen V, editors. Measles Virus. Berlin, Heidelberg, New York: Springer-Verlag; 1995; p. 117-134.
6. Schneider-Schaulies J, ter Meulen V, Schneider-Schaulies S. Measles virus interactions with cellular receptors: Consequences for viral pathogenesis. J Neurovirol 2001; 7: 391-399.
7. Okada H, Kobune F, Sato TA, et al. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol 2000; 145: 905-920.
8. Okada H, Sato T, Katayama A, et al. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Arch Virol 2001; 146: 859-874.
9. Arneborn P, Biberfeld G. T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infection and Immunity 1983; 39: 29-37.
10. Ryon JJ, Moss WJ, Monze M, et al. Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles. Clin Diagn Lab Immunol 2002; 9: 994-1003.
11. Fugier-Vivier I, Servet-Delprat C, Rivailler P, et al. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997; 186:813-823.
12. Grosjean I, Caux C, Bella C, et al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J Exp Med 1997; 186: 801-812.
13. Servet-Delprat C, Vidalain PO, Azocar O, et al. Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J Virol 2000; 74: 4387-4393.
14. Vidalain PO, Azocar O, Lamouille B, et al. Measles virus induces functional TRAIL production by human dendritic cells. J Virol 2000; 74: 556-559.
15. Vidalain PO, Azocar O, Rabourdin-Combe C, et al. Measles virus-infected dendritic cells develop immunosuppressive and cytotoxic activities. Immunobiology 2001; 204: 629-638.
16. Nanan R, Chittka B, Hadam M, et al. Measles virus infection causes transient depletion of activated T cells from peripheral circulation. J Clin Virol 1999; 12: 201-210.
17. Bellini WJ, Rota JS, Lowe LE, et al. Subacute sclerosing panencephalitis: More cases of this fatal disease are prevented by measles immunization than previously recognized. J Infect Dis 2005; 192: 1686-1693.
18. Weissbrich B, Schneider-Schaulies J, ter Meulen V. Measles and its neurological complications. New York: Marcel Dekker; 2003.
19. Cathomen T, Naim HY, Cattaneo R. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol 1998; 72: 1224-1234.
20. Cathomen T, Mrkic B, Spehner D, et al. A matrixless measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J 1998; 17: 3899-3908.
21. Pohl C, Duprex WP, Krohne G, et al. Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of viruslike particles. J Gen Virol 2007; 88: 1243-1250.
22. Reuter T, Weissbrich B, Schneider-Schaulies S, et al. RNA interference with measles virus N-, P-, and L-mRNAs efficiently prevents, and with matrix protein-mRNA enjances viral transcription. J Virol 2006; 80: 5951-5957.
23. Colf LA, Juo ZS, Garcia KC. Structure of the measles virus hemagglutinin. Nat Struct Mol Biol 2007; 14: 1227-1228.
24. Hashiguchi T, Kajikawa M, Maita N, et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A 2007; 104: 19535-19540.
25. Dörig RE, Marcil A, Chopra A, et al. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75: 295-305.
26. Naniche D, Varior-Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993; 67: 6025-6032.
27. Schneider-Schaulies J, Schnorr JJ, Brinckmann U, et al. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A 1995; 92: 3943-3947.
28. Schnorr JJ, Dunster LM, Nanan R, et al. Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur J Immunol 1995; 25: 976-984.
29. Erlenhoefer C, Wurzer WJ, Löffler S, et al. CD150 (SLAM) is a receptor for measles virus, but is not involved in viral contact-mediated proliferation inhibition. J Virol 2001; 75: 4499-4505.
30. Hsu EC, Iorio C, Sarangi F, et al. CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 2001; 279: 9-21.
31. Tatsuo H, Ono N, Tanaka K, et al. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406: 893-897.
32. Tatsuo H, Ono N, Yanagi Y. Morbilliviruses use signalling lymphocyte activation molecules (CD150) as cellular receptors. J Virol 2001; 75: 5842-5850.
33. Ono N, Tatsuo H, Tanaka K, et al. V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol 2001; 75: 1594-1600.
34. Yanagi Y, Takeda M, Ohno S. Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol 2006; 87: 2767-2779.
35. Baron MD. Wild-type Rinderpest virus uses SLAM (CD150) as its receptor. J Gen Virol 2005; 86: 1753-1757.
36. Tatsuo H, Yanagi Y. The morbillivirus receptor SLAM (CD150). Microbiol Immunol 2002; 46: 135-142.
37. Browning MB, Woodliff JE, Konkol MC, et al. The T cell activation marker CD150 can be used to identify alloantigen-activated CD4+25+ regulatory T cells. Cell Immunol 2004; 227: 129-139.
38. Aversa G, Chang C-CJ, Carballido JM,. Engagement of the signalling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J Immunol 1997; 158: 4036-4044.
39. Condack C, Grivel JC, Devaux P, et al. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 2007; 196: 541-549.
40. de Swart RL, Ludlow M, de Witte L, et al. Predominant Infection of CD150(+) Lymphocytes and Dendritic Cells during Measles Virus Infection of Macaques. PLoS Pathog 2007; 3: e178.
41. Esolen LM, Ward BJ, Moench TR, et al. Infection of moncytes during measles. J Infect Dis 1993; 168: 47-52.
42. Minagawa H, Tanaka K, Ono N, et al. Induction of the measles virus receptor SLAM (CD150) on monocytes. J Gen Virol 2001; 82: 2913-2917.
43. Kruse M, Meinl E, Henning G, et al. Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1b. J Immunol 2001; 167: 1989-1995.
44. Welstead GG, Hsu EC, Iorio C, et al. Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein. J Virol 2004; 78: 9666-9674.
45. Mikhalp SV, Shlapatska LM, Berdowa AG, et al. CDw150 associates with Src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. J Immunol 1999; 162: 5719-5727.
46. Cocks BG, Chang C-CJ, Carballido JM, et al. A novel receptor involved in T-cell activation. Nature 1995; 376: 260-263.
47. Engel P, Eck MJ, Terhost C. The SAP and SLAM families in immune response and X-linked lymphoproliferative disease. Nat Rev Immunol 2003; 3: 813-821.
48. Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003; 4: 19-24.
49. Wang N, Satoskar A, Faubion W, et al. The cell surface recepor SLAM controls T cell and macrophage functions. J Exp Med 2004; 199: 1255-1264.
50. Andres O, Obojes K, Kim KS, et al. CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J Gen Virol 2003; 84: 1189-1197.
51. Takeuchi K, Miyajima N, Nagata N, et al. Wildtype measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res 2003; 94: 11-16.
52. Takeda M, Tahara M, Hashiguchi T, et al. A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAMand CD46-independent mechanism. J Virol 2007; 81: 12091-12096.
53. Dunster LM, Schneider-Schaulies J, Loffler S, et al. Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology 1994; 198: 265-274.
54. Harrowe G, Sudduth-Klinger J, Payan DG. Measles virus-substance P receptor interaction: Jurkat lymphocytes transfected with substance P receptor cDNA enhance measles virus fusion and replication. Cell Mol Neurobiol 1992; 12: 397-409.
55. Bieback K, Lien E, Klagge I, et al. The hemagglutinin protein of wildtype measles virus activates Toll-like receptor 2 signaling. J Virol 2002; 76: 8729-8736.
56. Ravanel K, Castelle C, Defrance T, et al. Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. J Exp Med 1997; 186: 269-278.
57. de Witte L, Abt M, Schneider-Schaulies S, et al. Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 2006; 80: 3477-3486.
58. de Witte L, de Vries RD, van der Vlist M, et al. DCSIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog 2008; 4: e1000049.
59. Tahara M, Takeda M, Shirogane Y, et al. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol 2008; 82: 4630-4637.
60. Leonard VH, Sinn PL, Hodge G, et al. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J Clin Invest 2008; 118: 2448-2458.
61. Forthal DN, Aarnaes S, Blanding J, et al. Degree and length of viremia in adults with measles. J Infect Dis 1992; 166: 421-424.
62. Schneider-Schaulies S, Kreth HW, Hofmann G, et al. Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases. Virology 1991; 182: 703-711.
63. von Messling V, Milosevic D, Cattaneo R. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A 2004; 101: 14216-14221.
64. Niewiesk S, Eisenhuth I, Fooks A, et al. Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol 1997; 71: 7214-7219.
65. Pfeuffer J, Püschel K, ter Meulen V, et al. Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (sigmodon hispidus). J Virol 2003; 77: 150-158.
66. Wyde PR, Ambrosi MW, Voss TG, et al. Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proc Soc Exp Biol Med 1992; 201: 80-87.
67. Hahm B, Arbour N, Oldstone MB. Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. Virology 2004; 323: 292-302.
68. Hahm B, Cho JH, Oldstone MB. Measles virusdendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. Virology 2007; 358: 251-257.
69. Haines DM, Martin KM, Chelack BJ, et al. Immunohistochemical detection of canine distemper virus in haired skin, nasal mucosa, and footpad epithelium: a method for antemortem diagnosis of infection. J Vet Diagn Invest 1999; 11: 396-399.
70. Kimura A, Tosaka K, Nakao T. Measles rash I. Light and electron microscopicstudy of skin eruptions. Archives of Virol 1975; 47: 295-307.
71. Cosby SL, Brankin B. Measles virus infection of cerebral endothelial cells and effect on their adhesive properties. Veterinary Microbiology 1995; 44: 135-139.
72. Fournier JG, Tardieu M, Lebon P, et al. Detection of measles virus RNA in lymphocytes from peripheralblood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis. N Engl J Med 1985; 313: 910-915.
73. McQuaid S, Kirk J, Zhou AL, et al. Measles virus infection of cells in perivascular infiltrates in the brain in subacute sclerosing panencephalitis: confirmation by non-radioactive in situ hybridization, immunocytochemistry and electron microscopy. Acta Neuropathol 1993; 85: 154-158.
74. Scheifele DW, Forbes CE. Prolonged giant cell excretion in severe African measles. Pediatrics 1972; 50: 867-873.
75. Moench TR, Griffin DE, Obriecht CR, et al. Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis 1988; 158: 433-442.
76. Esolen LM, Takahashi K, Johnson RT, et al. Brain endothelial cell infection in children with acute fatal measles. J Clin Invest 1995; 96: 2478-2481.
77. Allen IV, McQuaid S, McMahon J, et al. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J Neuropathol Exp Neurol 1996; 55: 471-480.
78. Isaacson SH, Asher DM, Godec MS, et al. Widespread, restricted low-level measles virus infection of brain in a case of subacute sclerosing panencephalitis. Acta Neuropathol 1996; 91: 135-139.
79. Kirk J, Zhou AL, McQuaid S, et al. Cerebral endothelial cell infection by measles virus in subacute sclerosing panencephalitis: ultrastructural and in situ hybridization evidence. Neuropathol Appl Neurobiol 1991; 17: 289-297.
80. Dittmar S, Harms H, Runkler N, et al. Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers. J Virol 2008; 82: 11273-11282.
81. Oldstone MBA, Dales S, Tishon A, et al. A role for dual hits in causation of subacute sclerosing panencephalitis. J Exp Med 2005; 202: 1185-1190.